Ortivus AB ser. A (ORTI-A) - Net Assets

Latest as of March 2026: Skr21.24 Million SEK ≈ $2.29 Million USD

Based on the latest financial reports, Ortivus AB ser. A (ORTI-A) has net assets worth Skr21.24 Million SEK (≈ $2.29 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr68.95 Million ≈ $7.42 Million USD) and total liabilities (Skr47.71 Million ≈ $5.13 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Ortivus AB ser. A tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr21.24 Million
% of Total Assets	30.8%
Annual Growth Rate	-9.95%
5-Year Change	-23.88%
10-Year Change	329.22%
Growth Volatility	95.23

Ortivus AB ser. A - Net Assets Trend (2003–2025)

This chart illustrates how Ortivus AB ser. A's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Ortivus AB ser. A to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Ortivus AB ser. A (2003–2025)

The table below shows the annual net assets of Ortivus AB ser. A from 2003 to 2025. For live valuation and market cap data, see how much is Ortivus AB ser. A worth.

Year	Net Assets	Change
2025-12-31	Skr22.41 Million ≈ $2.41 Million	+412.83%
2024-12-31	Skr-7.17 Million ≈ $-771.07K	-141.40%
2023-12-31	Skr17.30 Million ≈ $1.86 Million	-51.16%
2022-12-31	Skr35.44 Million ≈ $3.81 Million	+20.35%
2021-12-31	Skr29.44 Million ≈ $3.17 Million	+49.63%
2020-12-31	Skr19.68 Million ≈ $2.12 Million	+124.79%
2019-12-31	Skr8.75 Million ≈ $942.07K	+301.38%
2018-12-31	Skr2.18 Million ≈ $234.71K	-85.98%
2017-12-31	Skr15.55 Million ≈ $1.67 Million	+197.87%
2016-12-31	Skr5.22 Million ≈ $561.97K	-57.76%
2015-12-31	Skr12.36 Million ≈ $1.33 Million	-36.10%
2014-12-31	Skr19.35 Million ≈ $2.08 Million	+12.41%
2013-12-31	Skr17.21 Million ≈ $1.85 Million	-44.81%
2012-12-31	Skr31.19 Million ≈ $3.36 Million	+7.43%
2011-12-31	Skr29.03 Million ≈ $3.12 Million	-56.64%
2010-12-31	Skr66.95 Million ≈ $7.20 Million	-20.89%
2009-12-31	Skr84.63 Million ≈ $9.11 Million	-20.55%
2008-12-31	Skr106.52 Million ≈ $11.46 Million	-34.66%
2007-12-31	Skr163.02 Million ≈ $17.54 Million	-27.88%
2006-12-31	Skr226.03 Million ≈ $24.32 Million	-1.61%
2005-12-31	Skr229.72 Million ≈ $24.72 Million	+2.34%
2004-12-31	Skr224.47 Million ≈ $24.16 Million	-0.27%
2003-12-31	Skr225.09 Million ≈ $24.22 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Ortivus AB ser. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1124.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Skr31.02 Million	138.37%
Other Comprehensive Income	Skr563.00K	2.51%
Other Components	Skr69.42 Million	309.71%
Total Equity	Skr22.41 Million	100.00%

Ortivus AB ser. A Competitors by Market Cap

The table below lists competitors of Ortivus AB ser. A ranked by their market capitalization.

Company	Market Cap
CABASSE S.A. EO -50 F:LB0	$397.26K
James Cropper PLC LSE:CRPR	$401.08K
PCI-PAL PLC LSE:PCIP	$401.10K
Premier Health of America Inc V:PHA	$401.58K
Anexo Group Plc LSE:ANX	$393.45K
CT UK High Income Trust Plc LSE:CHIB	$392.64K
Pebble Beach Systems Group PLC LSE:PEB	$392.41K
Quintegra Solutions Limited NSE:QUINTEGRA	$391.47K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ortivus AB ser. A's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from -7,165,000 to 22,414,000, a change of 29,579,000.
Net loss of 21,876,000 reduced equity.
Share repurchases of 52,139,000 reduced equity.
Other comprehensive income decreased equity by 683,000.
Other factors increased equity by 104,277,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr-21.88 Million	-97.6%
Share Repurchases	Skr52.14 Million	-232.62%
Other Comprehensive Income	Skr-683.00K	-3.05%
Other Changes	Skr104.28 Million	+465.23%
Total Change	Skr-	%

Book Value vs Market Value Analysis

This analysis compares Ortivus AB ser. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 5.05x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 0.21x to 5.05x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2003-12-31	Skr10.28	Skr2.20	x
2004-12-31	Skr10.25	Skr2.20	x
2005-12-31	Skr10.49	Skr2.20	x
2006-12-31	Skr8.13	Skr2.20	x
2007-12-31	Skr4.86	Skr2.20	x
2008-12-31	Skr3.21	Skr2.20	x
2009-12-31	Skr2.58	Skr2.20	x
2010-12-31	Skr2.04	Skr2.20	x
2011-12-31	Skr0.88	Skr2.20	x
2012-12-31	Skr0.95	Skr2.20	x
2013-12-31	Skr0.52	Skr2.20	x
2014-12-31	Skr0.59	Skr2.20	x
2015-12-31	Skr0.38	Skr2.20	x
2016-12-31	Skr0.21	Skr2.20	x
2017-12-31	Skr0.52	Skr2.20	x
2018-12-31	Skr0.07	Skr2.20	x
2019-12-31	Skr0.23	Skr2.20	x
2020-12-31	Skr0.44	Skr2.20	x
2021-12-31	Skr0.66	Skr2.20	x
2022-12-31	Skr0.80	Skr2.20	x
2023-12-31	Skr0.39	Skr2.20	x
2024-12-31	Skr-0.16	Skr2.20	x
2025-12-31	Skr0.44	Skr2.20	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ortivus AB ser. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -97.60%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -29.80%
• Asset Turnover: 1.03x
• Equity Multiplier: 3.16x
Recent ROE (-97.60%) is below the historical average (-68.76%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2003	3.41%	4.38%	0.67x	1.17x	Skr-14.83 Million
2004	5.79%	9.23%	0.54x	1.15x	Skr-9.45 Million
2005	-7.71%	-10.21%	0.49x	1.55x	Skr-40.68 Million
2006	-66.00%	-74.68%	0.60x	1.48x	Skr-171.79 Million
2007	-37.60%	-37.74%	0.64x	1.55x	Skr-77.59 Million
2008	-64.73%	-82.95%	0.46x	1.70x	Skr-79.60 Million
2009	-21.84%	-17.59%	0.64x	1.94x	Skr-26.94 Million
2010	-33.27%	-46.66%	0.57x	1.25x	Skr-28.97 Million
2011	-130.41%	-82.76%	0.90x	1.76x	Skr-40.76 Million
2012	7.12%	3.66%	1.14x	1.71x	Skr-898.70K
2013	-81.59%	-38.89%	0.98x	2.14x	Skr-15.76 Million
2014	7.24%	2.02%	0.84x	4.28x	Skr-534.70K
2015	-57.35%	-9.76%	1.10x	5.34x	Skr-8.33 Million
2016	-135.56%	-9.53%	1.57x	9.05x	Skr-7.60 Million
2017	-74.61%	-19.74%	1.70x	2.22x	Skr-13.16 Million
2018	-613.98%	-25.65%	1.88x	12.70x	Skr-13.61 Million
2019	-182.84%	-31.48%	1.46x	3.99x	Skr-16.88 Million
2020	57.59%	10.53%	1.62x	3.38x	Skr9.36 Million
2021	31.28%	9.77%	1.30x	2.46x	Skr6.27 Million
2022	16.63%	5.64%	1.16x	2.53x	Skr2.35 Million
2023	-105.43%	-21.70%	1.16x	4.20x	Skr-19.98 Million
2024	0.00%	-30.97%	1.26x	0.00x	Skr-24.19 Million
2025	-97.60%	-29.80%	1.03x	3.16x	Skr-24.12 Million

Industry Comparison

This section compares Ortivus AB ser. A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $738,954,333
Average return on equity (ROE) among peers: -101.75%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Ortivus AB ser. A (ORTI-A)	Skr21.24 Million	3.41%	2.25x	$393.65K
ADDvise Group AB A (ADDV-A)	$2.32 Million	-41.78%	4.56x	$4.23 Million
ADDvise Group B (ADDV-B)	$247.28 Million	1.13%	3.32x	$108.58 Million
AddLife AB (publ) (ALIF-B)	$4.97 Billion	9.66%	1.63x	$1.96 Billion
Biotage AB (BIOT)	$902.36 Million	0.00%	0.06x	$1.23 Billion
Bio-Works Technologies AB (BIOWKS)	$37.46 Million	-118.94%	0.21x	$38.42 Million
Bonesupport Holding AB (BONEX)	$265.70 Million	-32.19%	0.29x	$1.49 Billion
Dynavox Group (DYVOX)	$210.60 Million	23.08%	5.28x	$717.33 Million
iZafe Group AB Series B (IZAFE-B)	$11.69 Million	-142.71%	2.05x	$18.00 Million
Ortivus AB ser. B (ORTI-B)	$2.18 Million	-613.98%	11.70x	$17.17 Million

About Ortivus AB ser. A

ST:ORTI-A Sweden Medical Instruments & Supplies

Market Cap

$393.65K

Skr3.66 Million SEK

Market Cap Rank

#30915 Global

#732 in Sweden

Share Price

Skr2.20

Change (1 day)

-4.35%

52-Week Range

Skr1.30 - Skr3.50

All Time High

Skr33.60